EUCTR2004-004835-72-GB
Active, not recruiting
Not Applicable
A study to determine the effects of growth hormone (GH) replacement therapy on quality of life and cardiovascualr risk in GH deficient adults - Growth Hormone and Quality of Life (GroH-QoL)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Birmingham
- Enrollment
- 200
- Status
- Active, not recruiting
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged over 18
- •Able to provide informed consent
- •Severe GH deficiency in adult life
- •No GH replacement for six months
- •Other hormone therapy stable over preceding six months
- •Life expectancy \> 15 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
Exclusion Criteria
- •Active malignant disease
- •Active Cushing's disease or active acromegaly
- •Breast feeding
- •Proliferative diabetic retinopathy
- •Sensitivity to GH or it preservative
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Growth hormone deficiency and clottingISRCTN59234325eeds Teaching Hospitals NHS Trust (UK)140
Not yet recruiting
Phase 3
Investigating the results of adding growth hormone to the ovulation stimulation regimen in microinjection and In Vitro Fertilization in patients with low ovarian reserveIRCT20130603013566N13Vice chancellor for Research,Tabriz University Of Medical Sciences96
Completed
Not Applicable
The effects of growth hormone (GH) on the results of echocardiography in patients with heart failure (HF) four weeks after myocardial infarction (MI)IRCT201704083035N1Vice chancellor for research, School of Medicine, Isfahan University of Medical Sciences32
Recruiting
Phase 2
Effect of Gh on pregnancy outcome in RIFInfertility.Female infertility of other originN97.8IRCT20091012002576N34Tehran University of Medical Sciences60
Completed
Phase 1
Effects of Growth Hormone on the Nitric Oxide PathwayCardiovascular DiseaseNCT00470002Hannover Medical School16